Umbral Energy Corp Stock Canadian Securities Exchange
Equities
CA90420Y1088
Pharmaceuticals
Sales 2022 | 29.57 40.39 | Sales 2023 | 29.79 40.7 | Capitalization | 14.15M 19.32M |
---|---|---|---|---|---|
Net income 2022 | -24M -32.79M | Net income 2023 | -20M -27.32M | EV / Sales 2022 | 1,474,984 x |
Net Debt 2022 | 11.54M 15.77M | Net Debt 2023 | 4.53M 6.19M | EV / Sales 2023 | 626,876 x |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-0.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Jasmine Paige
DFI | Director of Finance/CFO | - | 23-08-13 |
Clinton Sharples
CHM | Chairman | - | 13-05-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clinton Sharples
CHM | Chairman | - | 13-05-28 |
Céline Arsenault
BRD | Director/Board Member | - | 19-02-07 |
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+37.15% | 6.12B | |
-16.04% | 4.44B | |
-11.16% | 3.14B | |
-1.40% | 3.03B | |
+0.12% | 2.57B | |
+38.69% | 1.87B | |
+1.11% | 1.63B | |
-10.34% | 1.62B | |
-12.97% | 1.53B |